Good morning, everyone, and how are you today? We apologize for the slow start, but we are returning from a much-needed long weekend and playing catch up takes some time, as you can imagine. A couple of thousand e-mails takes some concentration. Nonetheless, we are now gearing up for another busy day and, of course, have a cup of stimulation in hand. So time to dig in. Here, as always, are a few tidbits. Meanwhile, let us know if you hear anyything interesting. Have a great day and stay in touch...
Roche To Create 1,000 Jobs In China (Sonntagszeitung)
Amarin Win FDA OK For Fish Oil Pill (Bloomberg News)
Canadian Ministers Want Value Pricing For Generics (Pharma Times)
Gilead Single Hep C Pill Targets 2014 Approval (Bloomberg News)
Debate Over Rx Coupons Continues In Massachusetts (Boston Globe)
McKesson To Pay $151M To Settle Pricing Suit (Wall Street Journal)
Novartis Afinitor Drug Gets EU Nod For Breast Cancer (Reuters)
Many Connecticut High Prescribers Get Pharma Perks (CT Latino News)
India Consider Price Controls For Patented Drugs (Reuters)
FDA Messages On QBD Create Confusion (InPharma Technologist)
Vertex Cystic Fibrosis Drug Gets EU OK (Pharma Times)
Pfizer Ends License To Three Products With Acura Technology (Dow Jones)
EDITOR'S NOTE: Please check this post for updates during the day
2 Comments
I thought this was interesting.